• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    January AI Raises $8.8 Million in New Funding

    FDA Clears Ava Fertility Tracking Wearable Device

    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System

    Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably

    Japan to Lead APAC Assisted Reproductive Technology Devices Market
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Rethink Your Medtech ASC Strategy, Part 1

    Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

    Tips for Reigniting Your MDR/IVDR Preparation

    Three Major Innovation Opportunities for Biomedical Textiles

    Use Vertical Integration to Increase Productivity, Drive Innovation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Qosina Corp.

    MW Life Sciences

    FUTEK Advanced Sensor Technology Inc.

    Medbio LLC

    Forefront Medical Technology
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Refurbished Medical Equipment Testing and Certification Under the NEC

    Taking the First Step with Metal Components

    4 Trends Driving Medical Manufacturing in 2021

    Pioneering AI Solutions to Reinforce Healthcare Services

    The 8 Major Types of PPE Supply Chain Fraud
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Unicep

    Medbio LLC

    Forefront Medical Technology

    FUTEK Advanced Sensor Technology Inc.

    Concise Engineering
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Globalization: Will Your 2019 Regulatory Strategy Help You Win in 2020?

    Successful medtech leaders have ongoing regulatory strategies for their respective businesses.

    Globalization: Will Your 2019 Regulatory Strategy Help You Win in 2020?
    Related CONTENT
    • Mike on Medtech: Update on FDA's STeP Designation
    • Global Medical Device Venture Financing Deals Total $3.84 Billion in Q4 2020
    • FDA Clears B-Secur's HeartKey EKG/ECG Technology
    • Medtech Matters: Hologic’s Breast Health Happenings
    • Evolving Trends in the Medical and Orthopedic Devices Industry
    Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors09.06.19
    Successful medtech leaders have ongoing regulatory strategies for their respective businesses. Mention the words “regulatory impacts” and most industry professionals immediately think of requirements for getting new products to market. But the most effective regulatory strategies involve evaluating the impacts of regulatory bodies on both existing and future products (regardless of whether the innovation is incremental or disruptive).

    As 2019 winds down and medtech firms begin their strategic planning for 2020, it’s important for companies to determine whether their current regulatory strategy will be a “winning” one next year. It remains to be seen whether 2020’s regulatory issues will be headwinds or tailwinds. While it certainly can be argued that regulatory issues are beyond a company’s control (due to the changing nature of governmental policies), we contend that strategizing against the competition is usually “graded on the curve.” Creating (and maintaining) international market access for products allows organizations to commercially execute their game plans. Without market access, there is no chance to compete and, therefore, no opportunity to win.

    And, synergistically, good portfolio management (a topic for a future MPO column) in medtech includes a regulatory strategy that considers the impacts of all present and future products.

    To begin the conversation on regulatory strategy, let’s consider some real-world challenges currently facing the medtech industry.

    Global Regulatory Challenge: MDR
    Possible Scenario A: A European firm with a solid product portfolio and significant sales history on the continent knows the ingredients for EU market success. Not surprisingly, each of its legacy EU products has its own CE mark; some are best sellers and some are “also-rans.” What are the strategic choices?
    1. Re-certify all products to the new MDR before the May 2020 deadline. Although recertification can be time consuming and create internal bandwidth challenges, it will allow the company to maintain a competitive edge with its EU product portfolio. There are risks, however. In some cases, the new MDR has re-classified some categories of products, which may impact a company’s ability to be re-certified in time. There also are fewer notified bodies now to complete the certification process.
    2. Use the MDR deadline as a “portfolio management” opportunity by recertifying only the best selling products and allowing the certification for “also-rans” to expire (leaving the market). Using this tactic can boost profitability through the elimination of unsuccessful items and the assurance of core product availability. Yet deciding on the SKUs to cut could be troublesome (a product might sell well in Italy, for example, but could be considered an “also-ran” in other parts of Europe). Companies executing this strategy risk upsetting customers (and sales reps), though. The menace of timely recertification also exists with this approach.
    3. Delay recertification to the new MDR altogether and only recertify to the existing MDD directives. While this option gives companies a four-year “breather” to maintain existing products and reassess their future portfolio strategy, rivals with MDR certification could use their compliance as a competitive advantage. One of the main risks with delaying MDR recertification is the market and customer uncertainty it likely will create.
    Possible Scenario B: A company is developing a new product and must decide where to launch it. Assuming the organization is global and has international market access, there are several obvious choices (related to regulatory impacts).
    1. Launch in the United States with U.S. Food and Drug Administration (FDA) clearance. This option gives the product access to one of the world’s largest markets; however, an American debut takes significant organizational focus, which could delay introductions in other parts of the world. Moreover, FDA clearance is not a “slam dunk,” as the agency is currently under pressure to revamp its existing 510(k) predicate device allowances. Thus, a de novo pathway may be necessary, leading to new clinical requirements.
    2. Launch in the EU under the new MDR. Companies that achieve this regulatory milestone will have a distinct competitive advantage because it is becoming increasingly clear that many medtech firms will not meet the deadline for recertification. Nevertheless, the EU is not one market—rather, it is a collection of 27 (28 if Great Britain is counted) distinct countries, each with their own languages and cultural differences that must be considered when introducing  products. As previously stated, the major risks with this strategy are finding qualified notified bodies and recertifying products before the deadline.
    3. Launch somewhere else in the world. Introducing a product somewhere other than America or Europe could eventually provide companies with the market and clinical data necessary for FDA and EU clearances. The major downside to this approach is that products will not be exposed to two of the world’s largest medtech markets. Companies also should keep in mind that many international markets (Japan, China, etc.) have more stringent, time-consuming requirements than the United States, thus imperilling any 2020 launch timelines.
    Global Regulatory Challenge: China
    Possible Scenario A: A company with products in the Chinese market should ideally update its portfolio to maintain its competitive advantage. However, the China NMPA (National Medical Products Administration) has replaced the former CFDA (which was previously the SFDA). Domestic companies are struggling with the requirements of the NMPA and its rules. What are the best strategic choices?
    1. File new product(s) with the NMPA and attempt to obtain clearance in 2020. Securing approval would provide a competitive advantage over other firms selling their wares in China (even some local companies). But such clearance is not attained easily—the NMPA requires new levels of clinical evidence that could be very costly. The main risk with this plan is IP protection—China has never really been the safest haven for proprietary technology, and with NMPA rules, companies may be required to disclose more proprietary data than which they are comfortable.
    2. Continue selling existing products and refresh the marketing and sales execution to maintain/grow market share. This plan allows companies to focus on their current product lines and potentially clears a path to incremental profitability next year; the only drawback lies in the innovation offered. By focusing on current products, companies are not providing Chinese customers with their best technology, and they are leaving themselves vulnerable to competitors who successfully navigate the China NMPA.
    Possible Scenario B: A company is not in the Chinese market but the Middle Kingdom is one of the best possible international growth opportunities for its products. Strategic choices include:
    1. File for NMPA clearance in 2020, thus gaining access to one of the world’s largest medtech markets. But, as previously noted, obtaining clearance in China can be complicated and costly; using resources in this way for an unknown market opportunity for products that may or may not be successful there is a risky venture.
    2. Enter the Chinese market at some future point. This tactic enables companies to focus on generating incremental sales and EBITDA in their core markets but locks them out of China—a risky move that can significantly hinder future growth prospects.
    Another key challenge (opportunity) companies should consider while evaluating their 2020 regulatory strategies include the IMDRF (International Medical Device Regulators Forum), a group of countries working together to attain regulatory harmonization. The countries/regions include the United States, Brazil, China, Canada, the EU, Japan, Russia, Singapore, South Korea, and Australia.

    While this initiative sounds promising, we remain skeptical about the ability of these regulatory bodies to play nice together. For example, the steps taken in the EU (with the new MDR) and in China (with the NMPA) seem contrary to the harmonization concept.

    We remain hopeful, however, that some of the players can find a way to actually harmonize their regulatory processes—i.e., creating easier international market access in the future. We’re not holding our breath but companies should stay tuned and take advantage if some positive results occur.

    Given the nature of this industry, the list of potential regulatory challenges could be a book. The previously mentioned issues are some of the most significant facing global businesses in the waning months of 2019. But they are not insurmountable. With the right strategy, these regulatory challenges can easily become competitive advantages. 


    Florence Joffroy-Black, CM&AA, is a longtime marketing and M&A expert with significant experience in the medical technology industry, including working for multi-national corporations based in the United States, Germany, and Israel. She is currently is CEO at MedWorld Advisors and can be reached at florencejblack@medworldadvisors.com.

    Dave Sheppard, CM&AA, is a former medical technology Fortune 500 executive and is now a Managing Director at MedWorld Advisors. He can be reached at davesheppard@medworldadvisors.com.  
    Related Searches
    • data
    • israel
    • clearance
    • it
    Suggested For You
    Medtech Matters: FDA’s Ambiguity on Hyaluronic Acid Medtech Matters: FDA’s Ambiguity on Hyaluronic Acid
    Mike on Medtech: Update on FDA Mike on Medtech: Update on FDA's STeP Designation
    Global Medical Device Venture Financing Deals Total $3.84 Billion in Q4 2020 Global Medical Device Venture Financing Deals Total $3.84 Billion in Q4 2020
    FDA Clears B-Secur FDA Clears B-Secur's HeartKey EKG/ECG Technology
    Medtech Matters: Hologic’s Breast Health Happenings Medtech Matters: Hologic’s Breast Health Happenings
    Evolving Trends in the Medical and Orthopedic Devices Industry Evolving Trends in the Medical and Orthopedic Devices Industry
    Medtech Matters: Optimizing Remote Electrophysiology Monitoring Medtech Matters: Optimizing Remote Electrophysiology Monitoring
    Apollo Endosurgery to Welcome New Leader Apollo Endosurgery to Welcome New Leader
    Pandemic-Level Playing Field: How COVID-19 Made Space for Progress Pandemic-Level Playing Field: How COVID-19 Made Space for Progress
    Global Trends in Medtech: OEMs and the Supply Chain Global Trends in Medtech: OEMs and the Supply Chain
    Perspectives on Post-Pandemic: Expect Supply Chain Security to Increase Perspectives on Post-Pandemic: Expect Supply Chain Security to Increase
    Perspectives on Post-Pandemic: For Manufacturers, Flexibility Is Key Perspectives on Post-Pandemic: For Manufacturers, Flexibility Is Key
    A Blueprint for Reducing Medtech Industry A Blueprint for Reducing Medtech Industry's Carbon Footprint
    Medtech Matters: Medtronic Medtech Matters: Medtronic's Robotic Surgery Status
    North American Medtech Deals Fall 17 Percent in Q4 2020 North American Medtech Deals Fall 17 Percent in Q4 2020

    Related Columns

    • Surgical
      Rethink Your Medtech ASC Strategy, Part 1

      Rethink Your Medtech ASC Strategy, Part 1

      ASCs have adopted a strategy to focus on predictable, low-risk procedures with lower complication rates in an out-of-hospital setting.
      Maria Shepherd, President and Founder, Medi-Vantage 02.03.21

    • R&D & Design
      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic restrictions may have diminished certain advantages large companies hold over small and mid-sized competitors.
      Dawn A. Lissy, President & Founder, Empirical 02.03.21

    • Tips for Reigniting Your MDR/IVDR Preparation

      Tips for Reigniting Your MDR/IVDR Preparation

      To get the MDR/IVDR preparation ball rolling again, here are four processes to help refocus on achieving compliance with the updated regulations.
      Nicolle Cannon, Founder and CEO, Cannon Quality Group LLC 02.03.21


    • Materials
      Three Major Innovation Opportunities for Biomedical Textiles

      Three Major Innovation Opportunities for Biomedical Textiles

      Biomedical textiles are gaining significant momentum for use in medical devices to facilitate less invasive surgical procedures.
      John Greco, Vice President of Sales, Cortland Biomedical 02.03.21

    • Contract Manufacturing
      Use Vertical Integration to Increase Productivity, Drive Innovation

      Use Vertical Integration to Increase Productivity, Drive Innovation

      The concept of vertical integration is simple: a company combining two or more stages of production that would normally be operated by separate companies.
      Ryan Lipe, Senior Vice President of Sales & Marketing, MGS 02.03.21

    • How to Better Prepare for Regulatory Requests and Minimize Impact

      How to Better Prepare for Regulatory Requests and Minimize Impact

      Pressure to increase efficiency in medical device development has been prevalent over the past year, especially with the intensified regulatory expectations.
      Sandi Schaible, Sherry Parker and Kim Ehman, WuXi AppTec Medical Device Testing 02.03.21


    • C-Suite Challenges in Medtech’s New Normal

      C-Suite Challenges in Medtech’s New Normal

      Many of the usual C-Suite management topics that are key to organizational success will remain the same this year.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 02.03.21

    • COVID-19: Accelerator of a Modern, Data-Driven Supplier Strategy

      COVID-19: Accelerator of a Modern, Data-Driven Supplier Strategy

      By the time COVID-19 arrived in the United States, global supply chains were already buckling under a historic level of demand.
      Denise Odenkirk, Vice President, Supplier Sales, Global Healthcare Exchange LLC 02.03.21

    • Fixing Face Mask Form and Function

      Fixing Face Mask Form and Function

      Masks for the general public are varied in both style and effectiveness.
      Sam Brusco, Associate Editor 11.04.20


    • Cardiovascular
      The Heart of the Matter: Trends in Cardiology

      The Heart of the Matter: Trends in Cardiology

      Of the three major segments of coronary stents, bioabsorbable stents are expected to have the highest growth between now and 2022.
      Maria Shepherd, President and Founder, Medi-Vantage 11.04.20

    • Virtually the Same? The Challenges of Online Conferences

      Virtually the Same? The Challenges of Online Conferences

      Like everyone else on the planet, I’m turning increasingly to virtual solutions to our physical challenges in the midst of a pandemic.
      Dawn A. Lissy, Founder & President, Empirical 11.04.20

    • Digital Health
      Digital Health Delivers During a Year for the Ages

      Digital Health Delivers During a Year for the Ages

      Internet of Medical Things technologies have emerged as the key enabler of a much more holistic and complete disease-state management toolbox.
      Brad Womble, Senior Director of Strategy, Marketing, and Mergers & Acquisitions, Jabil Healthcare 11.04.20


    • Advanced Technology for Staking and Swaging Medical Plastics

      Advanced Technology for Staking and Swaging Medical Plastics

      It reliably assembles heat- and vibration-sensitive components, and works with a wide range of plastic materials.
      Priyank Kishor, Global Product Manager—PulseStaking, Branson at Emerson 11.04.20

    • Quality Assurance When Supply Chain Disruptions Arise

      Quality Assurance When Supply Chain Disruptions Arise

      From supply chain disruptions to impromptu manufacturing modifications, the medical device industry has faced a whirlwind of complications in 2020.
      Sandi Schaible and Peter Steen, WuXi AppTec Medical Device Testing 11.04.20

    • The Top 30 and M&A in 2021: What’s Next?

      The Top 30 and M&A in 2021: What’s Next?

      With three of the top five companies appointing new CEOs in the last year and the global pandemic eroding earnings, M&A strategies could look a lot different.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 11.04.20


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    • TransEnterix Changes Name To Asensus Surgical
    • An Analysis Of The Smart Inhalers Market
    Breaking News
    • January AI Raises $8.8 Million in New Funding
    • FDA Clears Ava Fertility Tracking Wearable Device
    • First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    • Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably
    • Japan to Lead APAC Assisted Reproductive Technology Devices Market
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • Seeking a Revolution in Clinical Care Through AI
    • Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit
    • Addition by Subtraction: The Latest of Machining for Medtech
    • Innovation Incubators: An R&D Roundtable
    • Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Preliminary Study Links Markers of Impaired Bone Health to Vegan Diet
    Refined Grains Linked to Heart Attack Risk, Early Death
    Kappa Bioscience Extends Research Partnership For COVID-19 Research
    Coatings World

    Latest Breaking News From Coatings World

    Nippon Paint Marine Wins Korea Export Award
    Universal Display Corporation, PPG Expand Global Production of UniversalPHOLED Materials
    PPG Introduces Premium Iso-free Primer Surfacer, Catalyst
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    January AI Raises $8.8 Million in New Funding
    FDA Clears Ava Fertility Tracking Wearable Device
    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Spark Therapeutics Appoints CTO
    Cryoport Launches ESG Program
    U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Top Beauty Products of 2021, According to HelloGiggles
    Estée Lauder Taps Ana de Armas as Global Brand Ambassador
    Sephora Announces Significant Expansion
    Happi

    Latest Breaking News From Happi

    ACI Urges Senate to Approve Regan as EPA Administrator
    Estée Lauder Signs Actress Ana de Armas
    GUM Recalls Oral Spray
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Marshall & Bruce Adds Koenig & Bauer Rapida 106 41-Inch Seven-Color Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    FTA converts Forum & INFOFLEX to virtual events
    Xeikon launches two new digital label printing presses
    UFlex adds capacity in packaging films
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Texas Medical Technology Partners with My Protect Kit
    Mexico City Single-Use Plastics Ban Leads to Tampon Shortage
    Believe Diapers Launch in U.S.
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    First Implantation of CTL Amedica's Minimally Invasive Flex Tower
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login